COMPUTED DESCRIPTORS
| Molecular Weight | 558.5 g/mol |
|---|---|
| XLogP3 | 5.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 558.10724205 g/mol |
| Monoisotopic Mass | 558.10724205 g/mol |
| Topological Polar Surface Area | 118 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 960 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Cevoglitazar is a dual peroxisome proliferator-activated receptor (PPAR) agonist, with hypoglycemic activity. In addition to its beneficial effects on glucose and triglyceride (TG) plasma levels, cevoglitazar also decreases body weight gain and adiposity.